Torrent Pharma initiates recalls of over 8 lakh bottles of Losartan Potassium tablets
13th May 2019

Torrent Pharmaceuticals has initiated recall of over 8.82 lakh bottles of Losartan Potassium tablets, used for treatment of hypertension, from the US and Puerto Rico markets on account of deviations from the current good manufacturing norms.

The US-based arm of Torrent Pharmaceuticals is recalling 28,464 bottles of Losartan Potassium tablets USP in the strength of 25 mg manufactured by the parent company at its Indrad facility in Mehsana district. All the ongoing voluntary recalls of the hypertension treatment drug are class II recalls.

Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.